Xiaosheng Zhao, Jie Gao, Kun Shi, Chixiang Zhang, Wenliang Ma, Guo Lyu, Jun Zhang, Jing Lu, Qiangqiang Liu, Xianjin Luo, Kunru Yu, Jianguo Li, Qiang Ge, Jiming Cai, Chang Liu, Zhiyong Qian
摘要 (
)
PDF全文 (
)
HTML
可视化
收藏
Radioactive microspheres have demonstrated excellent therapeutic effects and good tolerance in the treatment of unresectable primary and secondary liver malignancies. This is attributed to precise embolization and potent anti-tumor effect. However, certain limitations such as unstable loading, perfusion stasis, heterogeneous distribution, ectopic distribution, and insufficient dosage, restrict their clinical application. Herein, a novel personalized Y-90 carbon microsphere with high uniformity, high specific activity and high availability (90Y-HUACM) is presented. It is synthesized through planar molecular complex adsorption and chemical deposition solidification. 90Y-HUACM exhibited controllable size, excellent biocompatibility, outstanding in vitro and in vivo stability. The radiolabeling efficiency of Y-90 exceeded 99% and the leaching rate of Y-90 is far below 0.1%. Furthermore, the excellent anti-tumor effect, nuclide loading stability, anti-reflux characteristics, precise embolization, and biosafety of 90Y-HUACM were validated in a rabbit VX2 liver tumor model. In summary, this new, high-performance, and customizable radioactive microsphere provides a superior choice for selective internal radiation treatment of advanced liver cancer is expected to be rapidly applied in clinical practice.